Product Information
LUMIGAN 0.01% EYE DROPS is a brand product labeled by Allergan, Inc., priced at $103.0104 per ML under NDC 00023320505. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Aug 31, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the bimatoprost market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.1 mg/mL
Manufacturer
Allergan, Inc.NDC
00023320505
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
BIMATOPROSTApproval Type
New Drug (NDA)
FDA Application
NDA022184FDA Approved
8/31/2010
TE Code
AB
On Market Since
9/10/2010
Pharmacological Classes
Price Statistics
The NADAC for LUMIGAN 0.01% EYE DROPS has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 150.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $103.0104 per ML |
|---|---|
| All-time high | $103.3019 (Jun 10, 2026) |
| All-time low | $40.8169 (Dec 18, 2013) |
| 52-week high | $103.3019 |
| 52-week low | $101.0384 |
| Median price | $79.3718 |
| Average price | $76.1326 |
| Largest weekly change | +9.9% (Jan 13, 2016) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LUMIGAN 0.01% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for LUMIGAN 0.01% EYE DROPS, manufactured by Allergan, Inc., is $103.0104 per ML (NDC 00023320505), effective Aug 19, 2026.
How has the price of LUMIGAN 0.01% EYE DROPS changed over time?
Over the history we have for it, the NADAC for LUMIGAN 0.01% EYE DROPS has risen 150.2%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LUMIGAN 0.01% EYE DROPS?
Since Nov 28, 2013, the NADAC for LUMIGAN 0.01% EYE DROPS has ranged from a low of $40.8169 (Dec 18, 2013) to a high of $103.3019 (Jun 10, 2026), with a median of $79.3718 per ML.
Are there cheaper alternatives to LUMIGAN 0.01% EYE DROPS?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LUMIGAN 0.01% EYE DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures LUMIGAN 0.01% EYE DROPS?
LUMIGAN 0.01% EYE DROPS (NDC 00023320505) is labeled by Allergan, Inc., and CMS classifies it as a brand product.